Is the primary use of generic (non-propietary) disease modifying therapies (DMTs) associated with therapeutic inertia in multiple sclerosis care?
MULTIPLE SCLEROSIS JOURNAL（2018）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要
MULTIPLE SCLEROSIS JOURNAL（2018）